ABCDx specializes in the discovery, clinical validation and commercialization of brain mobile diagnostic solutions with advanced blood-based biomarkers through it proprietary
Software as a Medical Device platform
Software as a Medical Device platform
Powered by data
About the founders
Prof. Sanchez & Dr Montaner Villalonga are recognized as Key Opinion Leaders in the field of brain biomarkers. They combine their unique expertise in brain biomarker discovery, awareness and clinical validation.
Their continuous discoveries of novel brain biomarkers constitute the IP portfolio of ABCDx and allow a rapid access to clinical validation for ABCDx’s medical devices.
what we do ?
Swiss based company, specialized in the discovery, clinical validation and commercialization of point-of-care disagnostics with advanced blood-based biomarkers for brain injuries
Discover more
Discover more
who we are ?
Swiss based company, specialized in the discovery, clinical validation and commercialization of point-of-care disagnostics with advanced blood-based biomarkers for brain injuries
Discover more
Discover more
news